| Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas C Palles, JB Cazier, KM Howarth, E Domingo, AM Jones, P Broderick, ... Nature genetics 45 (2), 136-144, 2013 | 1110 | 2013 |
| Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk AL Sherborne, FJ Hosking, RB Prasad, R Kumar, R Koehler, ... Nature genetics 42 (6), 492-494, 2010 | 318 | 2010 |
| Prediction of outcome in newly diagnosed myeloma: a meta-analysis of the molecular profiles of 1905 trial patients V Shah, AL Sherborne, BA Walker, DC Johnson, EM Boyle, S Ellis, ... Leukemia 32 (1), 102-110, 2018 | 246 | 2018 |
| The genetic basis of inbreeding avoidance in house mice AL Sherborne, MD Thom, S Paterson, F Jury, WER Ollier, P Stockley, ... Current biology 17 (23), 2061-2066, 2007 | 220 | 2007 |
| Variation at 10p12. 2 and 10p14 influences risk of childhood B-cell acute lymphoblastic leukemia and phenotype G Migliorini, B Fiege, FJ Hosking, Y Ma, R Kumar, AL Sherborne, ... Blood, the Journal of the American Society of Hematology 122 (19), 3298-3307, 2013 | 171 | 2013 |
| Rare disruptive mutations and their contribution to the heritable risk of colorectal cancer D Chubb, P Broderick, SE Dobbins, M Frampton, B Kinnersley, S Penegar, ... Nature communications 7 (1), 11883, 2016 | 161 | 2016 |
| Genetic diagnosis of high-penetrance susceptibility for colorectal cancer (CRC) is achievable for a high proportion of familial CRC by exome sequencing D Chubb, P Broderick, M Frampton, B Kinnersley, A Sherborne, ... Journal of Clinical Oncology 33 (5), 426-432, 2015 | 102 | 2015 |
| Clonal evolution in myeloma: the impact of maintenance lenalidomide and depth of response on the genetics and sub-clonal structure of relapsed disease in uniformly treated … JR Jones, N Weinhold, C Ashby, BA Walker, C Wardell, C Pawlyn, ... Haematologica 104 (7), 1440, 2019 | 89 | 2019 |
| Baculum morphology predicts reproductive success of male house mice under sexual selection P Stockley, SA Ramm, AL Sherborne, MDF Thom, S Paterson, JL Hurst BMC biology 11, 1-6, 2013 | 86 | 2013 |
| Developmental timing of mutations revealed by whole-genome sequencing of twins with acute lymphoblastic leukemia Y Ma, SE Dobbins, AL Sherborne, D Chubb, M Galbiati, G Cazzaniga, ... Proceedings of the National Academy of Sciences 110 (18), 7429-7433, 2013 | 76 | 2013 |
| The silent mutational landscape of infant MLL‐AF4 pro‐B acute lymphoblastic leukemia SE Dobbins, AL Sherborne, YP Ma, M Bardini, A Biondi, G Cazzaniga, ... Genes, Chromosomes and Cancer 52 (10), 954-960, 2013 | 71 | 2013 |
| Role of 657del5 NBN mutation and 7p12. 2 (IKZF1), 9p21 (CDKN2A), 10q21. 2 (ARID5B) and 14q11. 2 (CEBPE) variation and risk of childhood ALL in the Polish population A Pastorczak, P Górniak, A Sherborne, F Hosking, J Trelińska, M Lejman, ... Leukemia research 35 (11), 1534-1536, 2011 | 70 | 2011 |
| Rationale for an international consortium to study inherited genetic susceptibility to childhood acute lymphoblastic leukemia AL Sherborne, K Hemminki, R Kumar, CR Bartram, M Stanulla, ... Haematologica 96 (7), 1049, 2011 | 55 | 2011 |
| Variation at 7p12. 2 and 10q21. 2 influences childhood acute lymphoblastic leukemia risk in the Thai population and may contribute to racial differences in leukemia incidence J Vijayakrishnan, AL Sherborne, R Sawangpanich, S Hongeng, ... Leukemia & lymphoma 51 (10), 1870-1874, 2010 | 55 | 2010 |
| Multiple Hodgkin lymphoma–associated loci within the HLA region at chromosome 6p21. 3 L Moutsianas, V Enciso-Mora, YP Ma, S Leslie, A Dilthey, P Broderick, ... Blood, The Journal of the American Society of Hematology 118 (3), 670-674, 2011 | 52 | 2011 |
| Daratumumab, cyclophosphamide, bortezomib, lenalidomide, and dexamethasone as induction and extended consolidation improves outcome in ultra-high-risk multiple myeloma MF Kaiser, A Hall, K Walker, A Sherborne, RM De Tute, N Newnham, ... Journal of Clinical Oncology 41 (23), 3945-3955, 2023 | 41 | 2023 |
| Predicting ultrahigh risk multiple myeloma by molecular profiling: an analysis of newly diagnosed transplant eligible myeloma XI trial patients V Shah, AL Sherborne, DC Johnson, S Ellis, A Price, F Chowdhury, ... Leukemia 34 (11), 3091-3096, 2020 | 41 | 2020 |
| Subclonal TP53 copy number is associated with prognosis in multiple myeloma V Shah, DC Johnson, AL Sherborne, S Ellis, FM Aldridge, ... Blood, The Journal of the American Society of Hematology 132 (23), 2465-2469, 2018 | 41 | 2018 |
| Mutational analysis of ionizing radiation induced neoplasms AL Sherborne, PR Davidson, K Yu, AO Nakamura, M Rashid, ... Cell reports 12 (11), 1915-1926, 2015 | 39 | 2015 |
| Somatic and Germline TP53 Alterations in Second Malignant Neoplasms from Pediatric Cancer Survivors AL Sherborne, V Lavergne, K Yu, L Lee, PR Davidson, T Mazor, ... Clinical Cancer Research 23 (7), 1852-1861, 2017 | 37 | 2017 |
